Competitive Information - Abbott invests in di
Post# of 11802
Abbott invests in diabetes care start-up
Abbott has invested an undisclosed amount in Bigfoot Biomedical, a start-up creating diabetes care devices and systems.
Abbott and Bigfoot previously agreed to integrate Abbott's new continuous glucose monitor, FreeStyle Libre, with Bigfoot's insulin delivery systems.
Bigfoot raised $55 million in Series B financing, bringing its total funding to more than $90 million.
https://www.cnbc.com/2018/03/28/abbott-invest...dical.html